RCM
Radnor Capital Management Portfolio holdings
AUM
$627M
This Quarter Return
+7.55%
1 Year Return
+16.68%
3 Year Return
+58.27%
5 Year Return
+120.33%
10 Year Return
–
AUM
$627M
AUM Growth
+$627M
(+5%)
Cap. Flow
+$12.8M
Cap. Flow
% of AUM
2.05%
Top 10 Holdings %
Top 10 Hldgs %
27.39%
Holding
325
New
8
Increased
95
Reduced
71
Closed
6
Top Buys
| 1 |
O'Reilly Automotive
ORLY
|
$7.33M |
| 2 |
Illumina
ILMN
|
$2.08M |
| 3 |
BWX Technologies
BWXT
|
$1.5M |
| 4 |
Broadcom
AVGO
|
$1.21M |
| 5 |
Merck
MRK
|
$1.2M |
Top Sells
| 1 |
lululemon athletica
LULU
|
$1.19M |
| 2 |
Textron
TXT
|
$1.06M |
| 3 |
Hewlett Packard
HPE
|
$935K |
| 4 |
Crane NXT
CXT
|
$907K |
| 5 |
FedEx
FDX
|
$817K |
Sector Composition
| 1 | Healthcare | 17.21% |
| 2 | Technology | 16.47% |
| 3 | Financials | 15.68% |
| 4 | Industrials | 15.58% |
| 5 | Consumer Discretionary | 11.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Madison Square Garden
MSGE
$1.93B
| $864K | 0.14% |
21,612
| – | – |
|
177
Shell
SHEL
$215B
| $846K | 0.14% |
12,010
| – | – |
|
178
Henry Schein
HSIC
$8.44B
| $834K | 0.13% |
11,415
+180
| +2% | +$13.2K |
|
179
Amphenol
APH
$133B
| $812K | 0.13% |
8,224
| – | – |
|
180
Scotiabank
BNS
$77.6B
| $785K | 0.13% |
14,200
+500
| +4% | +$27.6K |
|
181
Carlisle Companies
CSL
$16.5B
| $777K | 0.12% |
2,080
| – | – |
|
182
Wells Fargo
WFC
$263B
| $777K | 0.12% |
9,701
| – | – |
|
183
Ross Stores
ROST
$48.1B
| $772K | 0.12% |
6,055
-15
| -0.2% | -$1.91K |
|
184
Ferguson
FERG
$46.4B
| $760K | 0.12% |
3,490
-40
| -1% | -$8.71K |
|
185
TC Energy
TRP
$54.1B
| $737K | 0.12% |
15,100
| – | – |
|
186
Dow Inc
DOW
$17.5B
| $736K | 0.12% |
27,809
-1,292
| -4% | -$34.2K |
|
187
GE HealthCare
GEHC
$33.7B
| $736K | 0.12% |
9,933
+478
| +5% | +$35.4K |
|
188
Church & Dwight Co
CHD
$22.7B
| $727K | 0.12% |
7,560
| – | – |
|
189
Colgate-Palmolive
CL
$67.9B
| $727K | 0.12% |
8,003
-7,000
| -47% | -$636K |
|
190
LCI Industries
LCII
$2.56B
| $716K | 0.11% |
7,850
-2,800
| -26% | -$255K |
|
191
Vanguard Dividend Appreciation ETF
VIG
$95.4B
| $708K | 0.11% |
3,459
| – | – |
|
192
iShares Core S&P 500 ETF
IVV
$662B
| $707K | 0.11% |
1,139
| – | – |
|
193
Chewy
CHWY
$16.9B
| $706K | 0.11% |
16,560
+2,620
| +19% | +$112K |
|
194
Vanguard FTSE Emerging Markets ETF
VWO
$96.4B
| $695K | 0.11% |
14,060
| – | – |
|
195
Novartis
NVS
$245B
| $693K | 0.11% |
5,725
+275
| +5% | +$33.3K |
|
196
HealthEquity
HQY
$7.72B
| $688K | 0.11% |
6,565
+525
| +9% | +$55K |
|
197
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $685K | 0.11% |
12,020
| – | – |
|
198
DaVita
DVA
$9.85B
| $684K | 0.11% |
4,800
| – | – |
|
199
TJX Companies
TJX
$152B
| $679K | 0.11% |
5,500
| – | – |
|
200
Brown & Brown
BRO
$32B
| $671K | 0.11% |
6,055
+65
| +1% | +$7.2K |
|